As of 2025-05-16, the Fair Value of SpringWorks Therapeutics Inc (SWTX) is -17.20 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 46.08 USD, the upside of SpringWorks Therapeutics Inc is -137.34%.
With the market price of 46.08 USD and our fair value calculation, SpringWorks Therapeutics Inc (SWTX) is not a good investment. Investing in SWTX stocks now will result in a potential loss of 137.34%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -45.57 | -173.91 | -277.42 | -325.10 | -258.13 | -216.03 |
| YoY growth | 21.85% | -281.63% | -59.52% | -17.19% | 20.60% | -63.18% |
| Market Cap (mil) | 3,456.92 |
| P/E | |
| Forward P/E |
| EPS | -3.44 |
| Avg earnings growth rate | -63.18% |
| TTM earnings | -258.13 |